STPG2
gene geneOn this page
Also known as MGC46496
Summary
STPG2 (sperm tail PG-rich repeat containing 2, HGNC:28712) is a protein-coding gene on chromosome 4q22.3-q23, encoding Sperm-tail PG-rich repeat-containing protein 2 (Q8N412).
At a glance
- GWAS associations: 64
- Clinical variants (ClinVar): 102 total
- MANE Select transcript:
NM_174952
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28712 |
| Approved symbol | STPG2 |
| Name | sperm tail PG-rich repeat containing 2 |
| Location | 4q22.3-q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC46496 |
| Ensembl gene | ENSG00000163116 |
| Ensembl biotype | protein_coding |
| Entrez | 285555 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000295268, ENST00000506482, ENST00000522676
RefSeq mRNA: 1 — MANE Select: NM_174952
NM_174952
CCDS: CCDS3645
Canonical transcript exons
ENST00000295268 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001071785 | 98128428 | 98128592 |
| ENSE00001071788 | 98143042 | 98143476 |
| ENSE00001071792 | 98134347 | 98134459 |
| ENSE00001235183 | 97840773 | 97840932 |
| ENSE00001235194 | 97943897 | 97944007 |
| ENSE00001235202 | 97972280 | 97972440 |
| ENSE00001235209 | 97981159 | 97981318 |
| ENSE00001235215 | 98105953 | 98106064 |
| ENSE00001235222 | 98109193 | 98109305 |
| ENSE00001434473 | 97558872 | 97559117 |
| ENSE00003673322 | 97712699 | 97712814 |
Expression profiles
Bgee: expression breadth ubiquitous, 113 present calls, max score 80.97.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2401 / max 48.9909, expressed in 674 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 53213 | 0.9129 | 537 |
| 53212 | 0.3272 | 158 |
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.55 | gold quality |
| buccal mucosa cell | CL:0002336 | 60.37 | silver quality |
| corpus callosum | UBERON:0002336 | 56.02 | gold quality |
| right uterine tube | UBERON:0001302 | 53.18 | gold quality |
| islet of Langerhans | UBERON:0000006 | 52.83 | gold quality |
| upper leg skin | UBERON:0004262 | 52.45 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 51.90 | gold quality |
| calcaneal tendon | UBERON:0003701 | 51.08 | silver quality |
| bone marrow cell | CL:0002092 | 50.51 | gold quality |
| adrenal tissue | UBERON:0018303 | 50.33 | gold quality |
| adenohypophysis | UBERON:0002196 | 50.30 | gold quality |
| pituitary gland | UBERON:0000007 | 50.25 | gold quality |
| thyroid gland | UBERON:0002046 | 50.05 | gold quality |
| prefrontal cortex | UBERON:0000451 | 49.87 | gold quality |
| testis | UBERON:0000473 | 49.78 | gold quality |
| metanephros cortex | UBERON:0010533 | 49.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 49.42 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 49.37 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 49.26 | gold quality |
| pancreas | UBERON:0001264 | 49.19 | gold quality |
| left testis | UBERON:0004533 | 49.18 | gold quality |
| kidney | UBERON:0002113 | 48.89 | gold quality |
| gall bladder | UBERON:0002110 | 48.66 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 48.53 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 48.46 | gold quality |
| right testis | UBERON:0004534 | 48.23 | gold quality |
| right lobe of liver | UBERON:0001114 | 47.93 | silver quality |
| body of pancreas | UBERON:0001150 | 47.80 | gold quality |
| cortex of kidney | UBERON:0001225 | 47.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting STPG2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-624-3P | 98.37 | 67.06 | 1067 |
| HSA-MIR-617 | 96.79 | 65.96 | 738 |
| HSA-MIR-382-5P | 96.71 | 65.90 | 762 |
| HSA-MIR-592 | 96.59 | 67.59 | 817 |
| HSA-MIR-3605-3P | 82.57 | 60.78 | 98 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | stpg2 | ENSDARG00000061060 |
| mus_musculus | Stpg2 | ENSMUSG00000047940 |
| rattus_norvegicus | Stpg2 | ENSRNOG00000023457 |
Paralogs (5): STPG1 (ENSG00000001460), CIMAP1A (ENSG00000177947), CIMAP1B (ENSG00000177989), CIMAP1D (ENSG00000181781), CIMAP1C (ENSG00000182950)
Protein
Protein identifiers
Sperm-tail PG-rich repeat-containing protein 2 — Q8N412 (reviewed: Q8N412)
All UniProt accessions (2): H0YAZ7, Q8N412
RefSeq proteins (1): NP_777612* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010736 | SHIPPO-rpt | Repeat |
| IPR051291 | CIMAP | Family |
Pfam: PF07004
UniProt features (16 total): repeat 9, sequence variant 6, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N412-F1 | 62.36 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, SCGGAAGY_ELK1_02, EIF4E_UP, RFX7_TARGET_GENES, ZNF423_TARGET_GENES, MIR6505_5P, MIR592, MIR617, LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB, DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS, CUX1_TARGET_GENES, ZNF236_TARGET_GENES, chr4q23
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
1146 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STPG2 | M1AP | Q8TC57 | 557 |
| STPG2 | EFCAB10 | A6NFE3 | 556 |
| STPG2 | METAP1 | P53582 | 508 |
| STPG2 | RAP1GDS1 | P52306 | 507 |
| STPG2 | DEFB125 | Q8N687 | 475 |
| STPG2 | CFAP206 | Q8IYR0 | 450 |
| STPG2 | CCDC169 | A6NNP5 | 447 |
| STPG2 | KBTBD12 | Q3ZCT8 | 446 |
| STPG2 | PRODH2 | Q9UF12 | 428 |
| STPG2 | AK8 | Q96MA6 | 418 |
| STPG2 | TSPAN5 | P62079 | 411 |
| STPG2 | SRCAP | Q6ZRS2 | 402 |
| STPG2 | FIGN | Q5HY92 | 402 |
| STPG2 | EXD1 | Q8NHP7 | 391 |
| STPG2 | TAFA1 | Q7Z5A9 | 379 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STPG2 | TF | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (11): TF (Affinity Capture-MS), TTC5 (Affinity Capture-MS), NYX (Affinity Capture-MS), TF (Affinity Capture-MS), NYX (Affinity Capture-MS), TTC5 (Affinity Capture-MS), TF (Affinity Capture-MS), NYX (Affinity Capture-MS), TTC5 (Affinity Capture-MS), GDA (Affinity Capture-MS), STPG2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A1A5R9, A2AVQ5, A2RRW4, A2RSX4, A5WUY6, A9JS51, B0BM24, B0S4Q5, B1H283, D4A039, F1MMV1, Q08BC4, Q0VB26, Q2T9Q3, Q2TA11, Q2TBS4, Q3KQ80, Q3SX64, Q3TZ65, Q3ZCV2, Q4KKZ1, Q4KLY8, Q4R5Y0, Q5PQN4, Q5RAF2, Q5XI56, Q6ZN84, Q810P2, Q8BUG5, Q8C008, Q8C8J0, Q8IXM7, Q8N412, Q8N6G2, Q8N7U6, Q8N801, Q8TCI5, Q8WW14, Q9D067, Q9D131
Diamond homologs: A1A5R9, Q08BC4, Q8C8J0, Q8N412
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
102 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 8 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1223 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:97580141:A:AC | donor_gain | 0.9900 |
| 4:97712813:ACCTG:A | acceptor_loss | 0.9900 |
| 4:97712814:CCTGA:C | acceptor_loss | 0.9900 |
| 4:97712815:C:CA | acceptor_loss | 0.9900 |
| 4:97712816:T:G | acceptor_loss | 0.9900 |
| 4:97712694:CAAA:C | donor_loss | 0.9800 |
| 4:97712695:AAAC:A | donor_loss | 0.9800 |
| 4:97712696:AACC:A | donor_loss | 0.9800 |
| 4:97712697:ACC:A | donor_loss | 0.9800 |
| 4:97712698:C:G | donor_loss | 0.9800 |
| 4:97712813:ACCT:A | acceptor_gain | 0.9800 |
| 4:97777116:T:C | donor_gain | 0.9800 |
| 4:97712699:C:G | donor_loss | 0.9700 |
| 4:97712812:GACCT:G | acceptor_gain | 0.9700 |
| 4:97720752:A:AC | donor_gain | 0.9700 |
| 4:97573346:T:C | donor_gain | 0.9600 |
| 4:97580145:CA:C | donor_gain | 0.9600 |
| 4:97712814:CCT:C | acceptor_gain | 0.9600 |
| 4:97712815:C:CC | acceptor_gain | 0.9600 |
| 4:97580118:A:AC | donor_gain | 0.9500 |
| 4:97712815:C:A | acceptor_gain | 0.9200 |
| 4:97712811:GGACC:G | acceptor_gain | 0.9100 |
| 4:97726935:T:TC | acceptor_gain | 0.9100 |
| 4:97717859:A:C | donor_gain | 0.9000 |
| 4:97751675:A:C | donor_gain | 0.9000 |
| 4:97590406:C:CC | acceptor_gain | 0.8900 |
| 4:97815028:C:CT | donor_gain | 0.8900 |
| 4:97815047:C:CT | donor_gain | 0.8900 |
| 4:97815048:T:TT | donor_gain | 0.8900 |
| 4:97682249:A:AC | donor_gain | 0.8800 |
AlphaMissense
2978 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:97981190:G:C | F247L | 0.949 |
| 4:97981190:G:T | F247L | 0.949 |
| 4:97981192:A:G | F247L | 0.949 |
| 4:98134443:A:C | F42L | 0.949 |
| 4:98134443:A:T | F42L | 0.949 |
| 4:98134445:A:G | F42L | 0.949 |
| 4:97840819:A:C | F386L | 0.942 |
| 4:97840819:A:T | F386L | 0.942 |
| 4:97840821:A:G | F386L | 0.942 |
| 4:97972355:A:C | F286L | 0.936 |
| 4:97972355:A:T | F286L | 0.936 |
| 4:97972357:A:G | F286L | 0.936 |
| 4:98109264:A:C | F143L | 0.930 |
| 4:98109264:A:T | F143L | 0.930 |
| 4:98109266:A:G | F143L | 0.930 |
| 4:97840813:A:C | S388R | 0.921 |
| 4:97840813:A:T | S388R | 0.921 |
| 4:97840815:T:G | S388R | 0.921 |
| 4:97981211:A:C | F240L | 0.913 |
| 4:97981211:A:T | F240L | 0.913 |
| 4:97981213:A:G | F240L | 0.913 |
| 4:98128453:C:T | G121D | 0.905 |
| 4:98128517:A:C | Y100D | 0.902 |
| 4:97840849:A:C | S376R | 0.901 |
| 4:97840849:A:T | S376R | 0.901 |
| 4:97840851:T:G | S376R | 0.901 |
| 4:98143132:G:T | R7S | 0.893 |
| 4:98128454:C:G | G121R | 0.885 |
| 4:98143140:C:G | R4P | 0.885 |
| 4:98109275:C:G | G140R | 0.875 |
dbSNP variants (sampled 300 via entrez): RS1000000990 (4:98120762 T>C), RS1000012789 (4:97898847 A>C), RS1000016655 (4:97523287 A>T), RS1000016974 (4:97497519 T>C), RS1000018908 (4:97922170 C>T), RS1000024927 (4:98035939 C>T), RS1000030488 (4:98120980 C>A,T), RS1000034127 (4:97711439 C>G), RS1000036110 (4:97891080 GAGAAC>G), RS1000040190 (4:98122186 T>C,G), RS1000044967 (4:97708370 A>C,G,T), RS1000044984 (4:97576979 C>T), RS1000053380 (4:97872735 C>T), RS1000056527 (4:97639385 C>T), RS1000057254 (4:97751916 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
64 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002157_3 | Response to mTOR inhibitor (everolimus) | 4.000000e-06 |
| GCST003264_1025 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_1039 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_1041 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_1044 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_1048 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_1049 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_1067 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1068 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1089 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1090 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1094 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1099 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1103 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_1106 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_143 | Post bronchodilator FEV1/FVC ratio | 2.000000e-06 |
| GCST003264_151 | Post bronchodilator FEV1/FVC ratio | 2.000000e-06 |
| GCST003264_153 | Post bronchodilator FEV1/FVC ratio | 2.000000e-06 |
| GCST003264_231 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_233 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_244 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_252 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_263 | Post bronchodilator FEV1/FVC ratio | 5.000000e-06 |
| GCST003264_266 | Post bronchodilator FEV1/FVC ratio | 5.000000e-06 |
| GCST003264_268 | Post bronchodilator FEV1/FVC ratio | 5.000000e-06 |
| GCST003264_294 | Post bronchodilator FEV1/FVC ratio | 4.000000e-06 |
| GCST003264_453 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_464 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_469 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
| GCST003264_492 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005417 | response to mTOR inhibitor |
| EFO:0004713 | FEV/FVC ratio |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008579 | risk-taking behaviour |
| EFO:0010093 | bitter non-alcoholic beverage consumption measurement |
| EFO:0006882 | suicide behaviour measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methyleugenol | decreases expression | 1 |
| bisphenol A | increases methylation, affects cotreatment | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Lead | decreases expression | 1 |
| Tobacco Smoke Pollution | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.